Steven W. Pipe, MD

Professor and Laurence A. Boxer Research Professor of Pediatrics and Professor of Pathology, University of Michigan and CS Mott Children’s Hospital, Ann Arbor, Michigan

Articles by Steven W. Pipe, MD

HOPE-B: 5-Year Etranacogene Dezaparvovec Maintains Durable Efficacy and Safety in Hemophilia B, With Steven Pipe, MD

BySteven W. Pipe, MD

December 10th 2025

End-of-study analysis from the HOPE-B trial shows durable endogenous FIX expression, reduced annualized bleeding rates, and a favorable safety profile.

Steven Pipe, MD | Image Credit: CS Motts Children's Hospital

Fitusiran Achieves Sustained Antithrombin Activity Regardless of Dose with Steven Pipe, MD

BySteven W. Pipe, MD

July 23rd 2025

A review of data from an ongoing phase 3 trial indicates the potential for a generalized, prespecified fitusiran treatment for hemophilia A and B.

Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia

ByVictoria Johnson,Steven W. Pipe, MD

January 6th 2025

Pipe discussed a symposium at ASH 2024 about practical implementation of gene therapy in the field.

Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions for Hemophilia

ByVictoria Johnson,Steven W. Pipe, MD

December 9th 2024

Pipe discussed findings from the open-label extension of the ATLAS studies at ASH 2024.

Steven W. Pipe, MD

Articles by Steven W. Pipe, MD

HOPE-B: 5-Year Etranacogene Dezaparvovec Maintains Durable Efficacy and Safety in Hemophilia B, With Steven Pipe, MD

Fitusiran Achieves Sustained Antithrombin Activity Regardless of Dose with Steven Pipe, MD

Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia

Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions for Hemophilia

Latest Updated Articles

Trending on HCPLive

SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study

Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B

Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial

Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs

What Are the Side Effects of Hair and Skin Supplements in Dermatology? With Rajani Katta, MD